BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25329493)

  • 1. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma.
    Bettinger D; Knüppel E; Euringer W; Spangenberg HC; Rössle M; Thimme R; Schultheiß M
    Aliment Pharmacol Ther; 2015 Jan; 41(1):126-36. PubMed ID: 25329493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
    Qiu B; Li K; Dong X; Liu FQ
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1372-1382. PubMed ID: 28488102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts.
    Kochar N; Tripathi D; McAvoy NC; Ireland H; Redhead DN; Hayes PC
    Aliment Pharmacol Ther; 2008 Aug; 28(3):294-303. PubMed ID: 19086235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Zou X; Xue M; Li J
    Med Sci Monit; 2021 Nov; 27():e934436. PubMed ID: 34840325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension.
    Hosokawa I; Adam R; Allard MA; Pittau G; Vibert E; Cherqui D; Sa Cunha A; Bismuth H; Miyazaki M; Castaing D
    Br J Surg; 2017 Mar; 104(4):443-451. PubMed ID: 28079252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.
    Geeroms B; Laleman W; Laenen A; Heye S; Verslype C; van der Merwe S; Nevens F; Maleux G
    Eur Radiol; 2017 May; 27(5):1795-1803. PubMed ID: 27629421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
    Kochar N; Tripathi D; Ireland H; Redhead DN; Hayes PC
    Gut; 2006 Nov; 55(11):1617-23. PubMed ID: 16571635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions.
    Khan F; Tripathi D
    World J Gastroenterol; 2021 Nov; 27(44):7612-7624. PubMed ID: 34908802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients.
    Stanley AJ; Jalan R; Forrest EH; Redhead DN; Hayes PC
    Gut; 1996 Sep; 39(3):479-85. PubMed ID: 8949658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years' follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre.
    Tripathi D; Helmy A; Macbeth K; Balata S; Lui HF; Stanley AJ; Redhead DN; Hayes PC
    Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):9-18. PubMed ID: 15095847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
    Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and rebleeding following Transjugular Intrahepatic Portosystemic Stent Shunt for variceal haemorrhage.
    Williams D; Waugh R; Gallagher N; Perkins K; Dilworth P; Duggan A; Selby W
    J Gastroenterol Hepatol; 1998 Feb; 13(2):163-9. PubMed ID: 10221818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
    Wei J; Li H; Li C
    J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.